Details

Autor(en) / Beteiligte

• Son, Hyo-Ju
• Sung, Heungsup
• Park, Se Yoon
• Kim, Taeeun
• Lee, Hyun Jeong
• Kim, Sun-Mi
• Chong, Yong Pil
• Lee, Sang-Oh
• Choi, Sang-Ho
• Kim, Yang Soo
• Woo, Jun Hee
• Kim, Sung-Han

Titel

Diagnostic performance of the -[beta]-D-glucan assay in patients with Pneumocystis jirovecii compared with those with candidiasis, aspergillosis, mucormycosis, and tuberculosis, and healthy volunteers

Ist Teil von

• PloS one, 2017-11, Vol.12 (11), p.e0188860

Ort / Verlag

Public Library of Science

Erscheinungsjahr

2017

Quelle

EZB Electronic Journals Library

Beschreibungen/Notizen

• Background Diagnosis of pneumocystis pneumonia (PCP) relies on microscopic visualization of P. jirovecii, or detection of Pneumocystis DNA in respiratory specimens, which involves invasive procedures such as bronchoalveolar lavage. The (1-3)-[beta]-D-glucan (BG) assay has been proposed as a less invasive and less expensive diagnostic test to rule out PCP. We therefore compared blood levels of BG in patients with PCP with those of patients with candidemia, chronic disseminated candidiasis (CDC), invasive aspergillosis, mucormycosis, and tuberculosis and those of healthy volunteers. Methods Adult patients who were diagnosed with PCP, candidemia, CDC, invasive aspergillosis, mucormycosis, and tuberculosis whose blood samples were available, and healthy volunteers were enrolled in a tertiary hospital in Seoul, South Korea, during a 21-month period. The blood samples were assayed with the Goldstream Fungus (1-3)-[beta]-D-glucan test (Gold Mountain River Tech Development, Beijing, China). Results A total of 136 individuals including 50 patients P. jirovecii,15 candidemia, 6 CDC, 15 invasive aspergillosis, 10 mucormycosis, and 40 controls (20 TB and 20 healthy volunteers) were included. The mean±SD of the concentration of 1-3-[beta]-D-glucan in the patients with PCP (290.08 pg/mL±199.98) were similar to those of patients with candidemia (314.14 pg/mL±205.60, p = 0.90 at an [alpha] = 0.005) and CDC (129.74 pg/mL±182.79, p = 0.03 at an [alpha] = 0.005), but higher than those of patients with invasive aspergillosis (131.62 pg/mL±161.67, p = 0.002 at an [alpha] = 0.005), mucormycosis (95.08 pg/mL±146.80, p<0.001 at an [alpha] = 0.005), and tuberculosis (103.31 pg/mL±140.81, p<0.001 at an [alpha] = 0.005) as well as healthy volunteers (101.18 pg/mL±197.52, p 31.25 pg/mL, which is highly sensitive for PCP versus tuberculosis plus healthy volunteers at the expense of specificity, the BG assay had a sensitivity of 92% (95% CI 81%-98%) and a specificity of 55% (95% CI 39%-71%). Conclusions The BG assay appears to be a useful adjunct test for PCP.